Volume | 285,422 |
|
|||||
News | - | ||||||
Day High | 47.38 | Low High |
|||||
Day Low | 45.63 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Soleno Therapeutics Inc | SLNO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
45.91 | 45.63 | 47.38 | 47.01 | 46.16 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,608 | 285,422 | $ 46.56 | $ 13,290,466 | - | 3.69 - 53.82 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:11:22 | 8 | $ 45.86 | USD |
Soleno Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.52B | 32.46M | - | 0 | -38.99M | -1.20 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Soleno Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLNO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 45.17 | 47.38 | 42.21 | 44.63 | 345,952 | 1.84 | 4.07% |
1 Month | 37.70 | 53.80 | 37.09 | 44.73 | 606,031 | 9.31 | 24.69% |
3 Months | 49.65 | 53.82 | 36.61 | 43.97 | 438,296 | -2.64 | -5.32% |
6 Months | 25.95 | 53.82 | 25.95 | 41.98 | 372,732 | 21.06 | 81.16% |
1 Year | 5.00 | 53.82 | 3.69 | 30.86 | 496,837 | 42.01 | 840.20% |
3 Years | 1.02 | 53.82 | 0.1302 | 6.67 | 864,603 | 45.99 | 4,508.82% |
5 Years | 1.95 | 53.82 | 0.1302 | 5.19 | 741,705 | 45.06 | 2,310.77% |
Soleno Therapeutics Description
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. |